Sysmex Corp. (SSMXF)
8.60
-0.15
(-1.71%)
USD |
OTCM |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.359B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -53.02% |
| Valuation | |
| PE Ratio | 18.03 |
| PE Ratio (Forward) | |
| PS Ratio | 1.598 |
| Price to Book Value | 1.677 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.1237 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.1418 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 82.85% |
Profile
| Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan. |
| URL | http://www.sysmex.co.jp/corporate/info/group.html |
| Investor Relations URL | https://www.sysmex.co.jp/en/ir/ |
| HQ State/Province | Hyogo |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | May. 13, 2026 (est.) |
| Last Earnings Release | Feb. 12, 2026 |
| Next Ex-Dividend Date | Mar. 31, 2026 |
| Last Ex-Dividend Date | Sep. 30, 2025 |
Profile
| Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan. |
| URL | http://www.sysmex.co.jp/corporate/info/group.html |
| Investor Relations URL | https://www.sysmex.co.jp/en/ir/ |
| HQ State/Province | Hyogo |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | May. 13, 2026 (est.) |
| Last Earnings Release | Feb. 12, 2026 |
| Next Ex-Dividend Date | Mar. 31, 2026 |
| Last Ex-Dividend Date | Sep. 30, 2025 |